InvestorsHub Logo
Followers 3183
Posts 208744
Boards Moderated 2
Alias Born 02/04/2004

Re: Samsa post# 22838

Wednesday, 02/01/2017 1:22:54 PM

Wednesday, February 01, 2017 1:22:54 PM

Post# of 38634

I seriously think licensing potential for other drugs is easily 30 to 50 million per drug.



My sentiments exactly...the PODRAS patent lists 180 applicable drugs...the potential is BILLIONS of dollars just from the PODRAS delivery tech platform.

It's years away still(at least 2 years of extensive human trials)...but PODRAS is a true blockbuster which could have global opioid manufacturers lined up to license IPCI's PODRAS technology.

For now though...Rexista and Regabatin deals alone possess phenomenal potential and then the entire much bigger picture will finally come into play including the 20 other opioid based NDA's in IPCI's pipeline they've been patiently waiting to reveal.


Never buy or sell based on my posts! My posts are just my opinion!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y